Showing Form 4 filings for ASPE
Pre-configured institutional-grade criteria for instant high-conviction screening
Multiple insiders buying stock within the last 30 days
Direct open-market purchases by Chief Executive Officers
Financial chiefs and top corporate officers accumulating shares
Institutional-scale insider purchases of $1,000,000 or greater
Insiders increasing their overall equity ownership by over 20%
High-value executive divestments by CEOs and CFOs over $1M
Aspen Neuroscience, Inc.
Price
$15.00
Shares
1,000,000
Ownership
3,589,132
Value/Share
Thompson Peter A.
Dir, 10%
Unknown
Industry
Orbimed Advisors LLC
1,333,333
2,361,074
Arch Venture Fund X, L.P.
10%
1,200,000
Arch Venture Partners Xiv, L.P.